Larry R. Brown, Sc.D.
About Larry R. Brown, Sc.D.
Larry R. Brown, Sc.D. Professional Title
Larry R. Brown serves as the Research & Development Executive Vice President and Chief Scientific Officer at Noveome. He joined the company in 2012, bringing with him extensive expertise in pharmaceutical research and development. With a role focused on leading scientific innovation, he oversees the company's R&D strategies to advance novel pharmaceutical formulations and product developments.
Larry R. Brown, Sc.D. Education and Expertise
Larry R. Brown earned his Doctor of Science (Sc.D.) in Biochemistry from the Massachusetts Institute of Technology (MIT). His academic background in biochemistry has significantly contributed to his extensive career in the pharmaceutical industry. Brown's expertise spans over 35 years, wherein he has worked with both startups and large pharmaceutical corporations, focusing on drug delivery, as well as research and development of new pharmaceutical products.
Larry R. Brown, Sc.D. Career Background
Before joining Noveome, Larry R. Brown held the position of Vice President of Research and corporate head of drug delivery at Baxter Healthcare Corporation. Throughout his career, he has been instrumental in conceiving, researching, and developing numerous novel pharmaceutical formulations. His work at Baxter and other organizations has solidified his reputation as a key figure in the pharmaceutical and biotechnology industries.
Larry R. Brown, Sc.D. Publications and Patents
Larry R. Brown has authored over 100 publications and holds several key patents in the field of pharmaceutical biotechnology. His contributions to scientific literature and patent portfolios reflect his deep knowledge and innovative approaches within the industry. These publications and patents have been instrumental in advancing the fields of drug delivery, diabetes treatment, and other biotechnology innovations.
Larry R. Brown, Sc.D. Speaking Engagements
Larry R. Brown is a frequent international industry speaker, sharing his insights at major pharmaceutical conferences. His speaking engagements often focus on drug delivery, advances in biotechnology, and diabetes treatment. Brown's role as a keynote speaker highlights his authority and expertise, enabling him to influence and inform peers and industry leaders globally.